Dental Ixekizumab is novel drug approved by the FDA for treatment of psoriasis, MOA of this drug is : A IL-17A agonist B IL-17A antagonist C IL-12/23 antagonist D PDE 4 inhibitor 💡 Explanation Ixekizumab is novel drug approved by the FDA for treatment of psoriasis, MOA of this drug is : ✓ Correct Answer: B. IL-17A antagonist